Literature DB >> 25366554

Mortality after first myocardial infarction in diabetic and non-diabetic people between 1985 and 2009. The MONICA/KORA registry.

Andrea Icks1, Heiner Claessen, Inge Kirchberger, Margit Heier, Annette Peters, Ines Trentinaglia, Guido Giani, Wolfgang von Scheidt, Christa Meisinger.   

Abstract

The aim of the study was to analyse mortality after a first myocardial infarction (MI) and its trends in people with diabetes compared to those without diabetes in Southern Germany, 1985-2009. Using data of the population-based MONICA/KORA Myocardial Infarction Registry, we ascertained all patients with a first fatal or non-fatal MI between 1985 and 2009 (n = 16,478, age 25-74 years, 71% male, 29% with diabetes). The impact of diabetes and calendar time on mortality was examined using multiple logistic and Cox regression. Survival improved with calendar time: The crude cumulative 5-year survival was 26.9 and 46.3% among diabetic and non-diabetic individuals (both sexes combined) with a first MI in the years 1985-1989, and 53.6 and 66.6% among those with a first MI in the years 2005-2009. This significant decrease of mortality was confirmed in multivariate analyses. The proportion of fatal first MIs was significantly higher in diabetic compared to non-diabetic patients [adjusted odds ratio (OR) 1.26; 95% confidence interval 1.17-1.36]. This association persisted in a similar manner between both sexes with no consistent change of OR over calendar time in which first MIs have been observed. Likewise, multiple adjusted risk of death after a non-fatal first MI was significantly higher among both diabetic men and women [hazard ratio (HR) 1.64; 1.47-1.82, 1.83; 1.55-2.14] with constant HR over calendar time. During the past 25 years, survival has improved in both diabetic and non-diabetic patients with incident MI in a similar manner. However, mortality after a first MI remained significantly higher in the diabetic population, particularly in women.

Entities:  

Mesh:

Year:  2014        PMID: 25366554     DOI: 10.1007/s10654-014-9964-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  13 in total

1.  Case fatality rates after first acute coronary syndrome in persons treated for type 2 diabetes show an improving trend.

Authors:  K M Winell; R Pääkkönen; A Pietilä; M K Niemi; A R Reunanen; V V Salomaa
Journal:  Diabetologia       Date:  2009-12-09       Impact factor: 10.122

2.  Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989-2000.

Authors:  A Rautio; V Lundberg; T Messner; S Nasic; B Stegmayr; M Eliasson
Journal:  J Intern Med       Date:  2005-10       Impact factor: 8.989

3.  Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era.

Authors:  Christa Meisinger; Allmut Hörmann; Margit Heier; Bernhard Kuch; Hannelore Löwel
Journal:  Int J Cardiol       Date:  2005-12-15       Impact factor: 4.164

4.  The disparity between long-term survival in patients with and without diabetes following a first myocardial infarction did not change between 1989 and 2006: an analysis of 6,776 patients in the Northern Sweden MONICA Study.

Authors:  M Eliasson; J-H Jansson; D Lundblad; U Näslund
Journal:  Diabetologia       Date:  2011-07-21       Impact factor: 10.122

5.  The population-based acute myocardial infarction (AMI) registry of the MONICA/KORA study region of Augsburg.

Authors:  H Löwel; C Meisinger; M Heier; A Hörmann
Journal:  Gesundheitswesen       Date:  2005-08

6.  Sex differences in survival after acute myocardial infarction in patients with diabetes mellitus (Worcester Heart Attack Study).

Authors:  Amber Crowley; Vandana Menon; Darleen Lessard; Jorge Yarzebski; Elizabeth Jackson; Joel M Gore; Robert J Goldberg
Journal:  Am Heart J       Date:  2003-11       Impact factor: 4.749

7.  Differences in trends in estimated incidence of myocardial infarction in non-diabetic and diabetic people: Monitoring Trends and Determinants on Cardiovascular Diseases (MONICA)/Cooperative Health Research in the Region of Augsburg (KORA) registry.

Authors:  A Icks; T Dickhaus; A Hörmann; M Heier; G Giani; B Kuch; C Meisinger
Journal:  Diabetologia       Date:  2009-07-15       Impact factor: 10.122

8.  Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

Authors:  H Tunstall-Pedoe; K Kuulasmaa; P Amouyel; D Arveiler; A M Rajakangas; A Pajak
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

9.  Case finding, data quality aspects and comparability of myocardial infarction registers: results of a south German register study.

Authors:  H Löwel; M Lewis; A Hörmann; U Keil
Journal:  J Clin Epidemiol       Date:  1991       Impact factor: 6.437

10.  Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus.

Authors:  H L Koek; S S Soedamah-Muthu; J W P F Kardaun; E Gevers; A de Bruin; J B Reitsma; M L Bots; D E Grobbee
Journal:  Eur J Epidemiol       Date:  2007-10-10       Impact factor: 8.082

View more
  6 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism.

Authors:  Zhen Zhang; Jing Wang; Yingwei Zhu; Hui Zhang; Hongxin Wang
Journal:  Mol Med Rep       Date:  2019-10-01       Impact factor: 2.952

Review 3.  HDL and glucose metabolism: current evidence and therapeutic potential.

Authors:  Andrew L Siebel; Sarah Elizabeth Heywood; Bronwyn A Kingwell
Journal:  Front Pharmacol       Date:  2015-10-31       Impact factor: 5.810

4.  FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats.

Authors:  Yue Xi; Da-Wei Gong; Zhenjun Tian
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

5.  Prevalence and temporal pattern of hospital readmissions for patients with type I and type II diabetes.

Authors:  Xiaoqian Liu; Yuanyuan Liu; Yuanjun Lv; Changping Li; Zhuang Cui; Jun Ma
Journal:  BMJ Open       Date:  2015-11-02       Impact factor: 2.692

6.  Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002-2014).

Authors:  José M de Miguel-Yanes; Rodrigo Jiménez-García; Valentín Hernández-Barrera; Manuel Méndez-Bailón; Javier de Miguel-Díez; Ana Lopez-de-Andrés
Journal:  Cardiovasc Diabetol       Date:  2017-10-10       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.